Clinical Trial Detail

NCT ID NCT02454972
Title Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PharmaMar
Indications

head and neck cancer

biliary tract cancer

germ cell cancer

carcinoma

lung small cell carcinoma

breast carcinoma

endometrial carcinoma

neuroendocrine tumor

Ewing sarcoma

Therapies

Lurbinectedin

Age Groups: senior adult

No variant requirements are available.